Held at the Grand Hall of the Lee Shau Kee Lecture Centre on the Centennial Campus, the forum drew an audience of over 800 ...
Reported $4.15 billion (YoY growth of +90%) in preliminary* full-year 2025 global product net sales, inclusive of $1.29 billion in fourth quarter sales VYVGART impact continues with approximately 19 ...
Royalty Pharma to provide up to $500 million, including $75 million for Phase 2b funding and a Royalty Pharma option for an additional $425 million, to support Teva's anti-IL-15 candidate, TEV-'408 TE ...
The biggest improvement was seen in Mathematics and Science, where animated explanations and interactive practice exercises ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback